OCPNF (Olympus) FCF Margin % : 22.12% (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Olympus FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Olympus's Free Cash Flow for the three months ended in Sep. 2024 was $370 Mil. Olympus's Revenue for the three months ended in Sep. 2024 was $1,673 Mil. Therefore, Olympus's FCF Margin % for the quarter that ended in Sep. 2024 was 22.12%.

As of today, Olympus's current FCF Yield % is 3.14%.

The historical rank and industry rank for Olympus's FCF Margin % or its related term are showing as below:

OCPNF' s FCF Margin % Range Over the Past 10 Years
Min: -2.38 Med: 3.7 Max: 14.39
Current: 8.45

During the past 13 years, the highest FCF Margin % of Olympus was 14.39%. The lowest was -2.38%. And the median was 3.70%.

OCPNF's FCF Margin % is ranked better than
75.88% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -4.42 vs OCPNF: 8.45

Olympus FCF Margin % Historical Data

The historical data trend for Olympus's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus FCF Margin % Chart

Olympus Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

8.95

8.88

14.39

3.16

-2.38

Olympus Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															12.10	-7.59	13.99	4.49	22.12

Competitive Comparison of Olympus's FCF Margin %

For the Medical Instruments & Supplies subindustry, Olympus's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Olympus's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Olympus's FCF Margin % falls into.

Olympus FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Olympus's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	-148.573	/	6248.957
	=	-2.38 %

Olympus's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	370.161	/	1673.321
	=	22.12 %

Olympus FCF Margin % Related Terms

Thank you for viewing the detailed overview of Olympus's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Olympus Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (OTCPK:OCPNF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

OLYMY:USA 7733:Japan OLY1:Germany

Address

Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914

Website

http://www.olympus.co.jp

Olympus is a medical device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2024, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.